Viewing posts categorised under: BPS News
The primary objective of any R&D project is to make a product commercially viable as quickly as possible. As a result, it is vital that researchers use the correct technologies and methods from the start of the process to ensure the product can be suitably scaled up to meet demand. For a new ...
Read morePeptide chemistry has become a significant player in the therapeutics industry, with many large pharmaceutical companies entering into the interesting world of UNAAs, formic acid and pyridine. Peptides have held their own in the drug discovery world, against rival small molecule and biological th...
Read moreBiopharma Group is proudly sponsoring ‘Project Green’, an environmentally friendly non-profit initiative run by our local community centre, Unit 12 in Winnall, Winchester.
Our contribution allows ‘Project Green’ to launch a free bike hire and rental hub service, which residents can use to impro...
Read moreJoin us in welcoming Stephen Jones to the Biopharma Team! Our new Freeze Dryer Executive can help you clarify your project requirements and provide recommendations on the freeze dryer system that will meet your current and future lyophilisation needs!
Contact Stephen Jones today!
Contact us to...
Read moreWithin the pharmaceutical, biotechnology and industries alike, a common challenge is the replication of results when moving from the laboratory scale to commercial scale.
Many lab scale instruments can differ significantly from the equipment required to produce large volumes of the same materi...
Read moreTake a look at this Webinar Technote from Biopharma Group & SP Scientific which details the use of PROTAC Technology for Novel Drug Discovery.
To read the complete Technote, click the image below:
[/vc_column_text][vc_btn title="Contact Us!" color="primary" size="lg"...
Read moreThis article was written by Richard Lewis for BPS Crowthorne and was featured on P.32 in Issue 2 of Manufacturing & Supply Chain Magazine
Data Rich Processing - The Growing Necessity of R&D to GMP Manufacture
Improved diagnosis is driving precision in treatment, accompanied by i...
Read moreWhite Paper from SP Scientific: Putting Fill-Finish Customization Into Your Line of Sight
Take a look at this new white paper from John Erdner at SP Scientific which tackles the challenges of small-batch manufacturing in fill-finish programs.
To read the complete white paper, click the image ...
Read moreAn emerging modality of therapeutics called PROteolysis TArgeting Chimeras (PROTACs) could enable the design of new drugs targeting “undruggable” proteins, this development has led to great interest in the pharmaceutical and biotechnology industries. However, synthesis of PROTACs requires numerou...
Read more[vc_row][vc_column][vc_column_text]
White Paper from SP Scientific: Adoption of Controlled Ice Nucelation Technology, ControLyo
Take a look at this new white paper from Ian Whitehall at SP Scientific which discussed how employing controlled nucleation technology (ControLyo) can offer the benefi...
Read more
English
Chinese (Simplified)
Filipino
Finnish
French
German
Hindi
Italian
Japanese
Norwegian
Portuguese
Russian
Spanish
Swedish
Urdu
